SFX by Ex Libris Inc.

Title:	Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model
Source:	Journal of Medicinal Chemistry [0022-2623] Keenan, R M yr:1992

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Nawrath. "Volatile methyl esters of medium chain length from the bacterium Chitinophaga Fx7914." Chemistry & biodiversity 7.9 (2010): 2228-2253.
description	2.	Berellini, G. "Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists." Journal of medicinal chemistry 48.13 (2005): 4389-99.
description	3.	MIDDLEMISS, D. "C-LINKED PYRAZOLE BIARYL TETRAZOLES AS ANTAGONISTS OF ANGIOTENSIN-II." Bioorganic & medicinal chemistry letters 2.10 (1992): 1243-1246.
description	4.	Paliwal, Sarvesh K. "Quantitative structure activity relationship analysis of angiotensin II AT1 receptor antagonists." Medicinal chemistry research 19.5 (2010): 475-489.
description	5.	Holgado, R. "Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation." Nephrology, dialysis, transplantation 16.1 (2001): 117-20.
description	6.	Thomas, Andrew P. "New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives." Journal of medicinal chemistry 35.5 (1992): 877-885.
description	7.	Krovat, Eva M. "Non-Peptide Angiotensin II Receptor Antagonists: Chemical Feature Based Pharmacophore Identification." Journal of medicinal chemistry 46.5 (2003): 716-726.
description	8.	Masek, B B B. "Molecular shape comparison of angiotensin II receptor antagonists." Journal of medicinal chemistry (1993): 1230-1238.
description	9.	LIN, H S S. "NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - SYNTHETIC AND COMPUTATIONAL CHEMISTRY OF N-[[4-[2-(2H-TETRAZOL-5-YL)-1-CYCLOALKEN-1-YL]PHENYL]METHYL]IMIDAZOLE DERIVATIVES AND THEIR INVITRO ACTIVITY." Journal of medicinal chemistry 35.14 (1992): 2658-2667.
description	10.	Tahara, H. "A species difference in the transport activities of H-2 receptor antagonists by rat and human renal organic anion and cation transporters." The Journal of pharmacology and experimental therapeutics 315.1 (2005): 337-345.
description	11.	Datar, P. "CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists." Journal of molecular modeling 8.10 (2002): 290-301.
description	12.	Rella, M. "Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors." Journal of chemical information and modeling 2006. 708-716.
description	13.	Imaizumi, S. "Differential Bonding Interactions of Inverse Agonists of Angiotensin II Type 1 Receptor in Stabilizing the Inactive-state." Molecular endocrinology 22.Sep (2007): 139-146.
description	14.	ATWAL, Karnail S. "DIHYDROPYRIMIDINE ANGIOTENSIN-II RECEPTOR ANTAGONISTS." Journal of medicinal chemistry 35.25 (1992): 4751-4763.
description	15.	VANATTEN, MK. "A NOVEL SERIES OF SELECTIVE, NONPEPTIDE INHIBITORS OF ANGIOTENSIN-II BINDING TO THE AT(2) SITE." Journal of medicinal chemistry 36.25 (1993): 3985-3992.
description	16.	Warner, P. "Quinoline antifolate thymidylate synthase inhibitors: variation of the C2- and C4-substituents." Journal of medicinal chemistry 35.15 (1992): 2761-2768.
description	17.	Podlipnik, C. "Fast evaluation of molecular 3D shape similarity." Acta chimica Slovenica (2001): 325-331.
description	18.	MATSOUKAS, JM. "DIFFERENCES IN BACKBONE STRUCTURE BETWEEN ANGIOTENSIN-II AGONISTS AND TYPE-I ANTAGONISTS." Journal of medicinal chemistry 38.23 (1995): 4660-4669.
description	19.	Smalcelj, R. "Circulating hematopoietic progenitors are not altered in patients with post-transplant erythrocytosis." Haematologica 83.10 (1998): 948-9.
description	20.	Isaac, M. "Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-bioavailable 5-HT1D agonists." Bioorganic & medicinal chemistry letters 13.24 (2003): 4409-2633.